Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib
血栓性微血管病是 BCR-ABL1 酪氨酸激酶抑制剂普纳替尼引起心血管毒性的原因之一
期刊:Blood
影响因子:21
doi:10.1182/blood-2018-10-881557
Yllka Latifi, Federico Moccetti, Melinda Wu, Aris Xie, William Packwood, Yue Qi, Koya Ozawa, Weihui Shentu, Eran Brown, Toshiaki Shirai, Owen J McCarty, Zaverio Ruggeri, Javid Moslehi, Junmei Chen, Brian J Druker, Jose A López, Jonathan R Lindner